India Insulin Market
Review to 2018 - Intensifying Strategic Alliances Between Companies’
presents a comprehensive analysis of market size by value of major types of
insulin consumed in India. The report entails the segment wise market share
analysis and company profiles of major players in the insulin market in India.
The future analysis of the market has also been discussed in the report.
Review to 2018 - Intensifying Strategic Alliances Between Companies’
presents a comprehensive analysis of market size by value of major types of
insulin consumed in India. The report entails the segment wise market share
analysis and company profiles of major players in the insulin market in India.
The future analysis of the market has also been discussed in the report.
The diabetic population in India is largely treated with
human insulin solely due to the fact that it is cheaper as compared to analog
insulin. In FY’2013, human insulin held ~% of the total insulin market in India,
generating revenue of USD ~ million. The revenue from human insulin registered
a CAGR of 10.5% during FY’2008-FY’2013. Although the share of human insulin has
been more since FY’2008, the market captured by analog insulin has been growing
rapidly with a CAGR of 20.4% during FY’2008-FY’2013, increasing its share from
~% in FY’2008 to ~% in FY’2013.
human insulin solely due to the fact that it is cheaper as compared to analog
insulin. In FY’2013, human insulin held ~% of the total insulin market in India,
generating revenue of USD ~ million. The revenue from human insulin registered
a CAGR of 10.5% during FY’2008-FY’2013. Although the share of human insulin has
been more since FY’2008, the market captured by analog insulin has been growing
rapidly with a CAGR of 20.4% during FY’2008-FY’2013, increasing its share from
~% in FY’2008 to ~% in FY’2013.
India has become a very lucrative market for insulin
multinationals. Companies including Novo Nordisk, Eli Lilly and Sanofi dominate
the landscape and had a share of more than ~% in the Indian insulin market in
FY’2013. With superior product portfolios and marketing strategies, the 3
companies have gained a monopoly over the market. Domestic enterprises
including Biocon and Wockhardt therefore face stiff competition from the
foreign counterparts.
multinationals. Companies including Novo Nordisk, Eli Lilly and Sanofi dominate
the landscape and had a share of more than ~% in the Indian insulin market in
FY’2013. With superior product portfolios and marketing strategies, the 3
companies have gained a monopoly over the market. Domestic enterprises
including Biocon and Wockhardt therefore face stiff competition from the
foreign counterparts.
Key Topics Covered in
the Report
the Report
·
The market size of India insulin market in terms
of revenue
The market size of India insulin market in terms
of revenue
·
Market segmentation by insulin replacement
therapy and types of insulin
Market segmentation by insulin replacement
therapy and types of insulin
·
Government regulation and support schemes for
the Indian insulin market
Government regulation and support schemes for
the Indian insulin market
·
Pricing scenario of different insulin brands in
India
Pricing scenario of different insulin brands in
India
·
Trends and developments in India insulin market
Trends and developments in India insulin market
·
Growth drivers and challenges in India insulin
market
Growth drivers and challenges in India insulin
market
·
Market share of major players in the insulin
market in India
Market share of major players in the insulin
market in India
·
Market share of major players by types of
insulin
Market share of major players by types of
insulin
·
Company profiles of major players in the Indian
insulin market
Company profiles of major players in the Indian
insulin market
·
Future outlook and projections of the insulin
market in India
Future outlook and projections of the insulin
market in India
Macroeconomic factors affecting the insulin
market in India
market in India
Browse and Download Report Here - http://www.kenresearch.com/healthcare/pharmaceutical-industry/india-insulin-market-research-report/573-91.html
No comments:
Post a Comment